E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/6/2008 in the Prospect News Special Situations Daily.

Allscripts, Misys transaction could close Friday following receipt of stockholder approval

By Lisa Kerner

Charlotte, N.C., Oct. 6 - Allscripts Healthcare Solutions, Inc. stockholders approved proposals related to the company's pending transactions with Misys plc on Monday.

According to Allscripts, over 97% of the total shares that voted at its annual meeting were in favor of the proposals.

Shareholders approved the issuance of shares to Misys, the amendment and restatement of Allscripts' certificate of incorporation required as a condition to the closing as well as a restatement of Allscripts' certificate of incorporation and bylaws, an Allscripts news release said.

Also on Monday, Misys shareholders passed the resolution to approve the proposed merger of Misys Healthcare Systems, LLC with a subsidiary of, and acquisition by Misys of a majority stake in, Allscripts.

Allscripts said it expects the transaction to close on or about Friday.

It was previously reported that Misys will pay $330 million in cash to Allscripts in exchange for 54.5% ownership of the combined company.

Allscripts will pay a special cash dividend totaling $330 million to its stockholders on Oct. 17. Record date for the dividend is Thursday.

It was previously reported that following the merger's close, Allscripts stockholders will retain the shares they currently own, and Allscripts shares will continue to trade on the Nasdaq under the symbol "MDRX."

Allscripts is a Chicago-based clinical software company. Misys is an applications software and services company located in London.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.